Targeting the ataxia telangiectasia mutated pathway for effective therapy against hirsutine-resistant breast cancer cells

Chenghua Lou(Zhejiang Chinese Medical University), Yoshihiro Hayakawa(University of Toyama)
Oncology Letters
May 11, 2016
Cited by 3


Related Papers